Global
Men's Medicine Market Surges Past $19 Billion
May 18, 2006
Male-specific medicine, still
a sensitive subject, has certainly benefited
from the heavy marketing and celebrity endorsements
which brought erectile
dysfunction out of the bedroom and into
the doctor's office. Over the last two years,
steady growth displayed in the sexual function,
sexually transmitted disease, cancer, and urinary
treatment segments have boosted the world market
for men's health products 7.5% -- from 2003's
$16.9 billion to $19.5 billion in 2005.
According to a new Kalorama Information study,
Men's
Health: The Worldwide Market for Current
and Emerging Drug Therapies, market growth will
continue at a rate of about 6%, with sales surpassing
$26 billion by 2010. A wide range of new product
approvals should also contribute to strong growth
in the BPH and incontinence segments and gains
in prostate and testicular cancer therapeutics.
While the men's sexual dysfunction
market has been one of the fastest growing segments
within the men's health industry, this highly
competitive market is becoming saturated. Kalorama
Information estimates that a slow down will
ensue over the next few years, bringing the
market once projected to reach $7 billion to
only $4.3 billion by 2010.
"Newer therapeutics are going to encroach
upon the market share of the most popular ED
pharmaceuticals, making this sector even more
competitive," notes Melissa Elder, the
report's author. "Concurrently, other sectors
will grow at a more rapid pace as global awareness
of men's health issues continues to receive
media and medical establishment attention. However,
more education is still needed, particularly
in Africa and Asia where high risk behaviors
among men are prevalent."
Covering drugs used to treat male-specific
conditions and conditions of major concern to
men, such as herpes and HIV, this 2nd Edition
of Men's Health also includes drug research
and development pipelines, in-depth company
profiles and competitive analysis, global statistics
on conditions and diseases affecting men, and
market estimates and forecasts for all segments.
Source: http://biz.yahoo.com/prnews/060518/nyth093.html?.v=54 |
